How much mutant protein is needed to cause a protein aggregate myopathy in vivo? Lessons from an exceptional

Christoph S Clemen1, Dirk Fischer, Jens Reimann

  • 1Institute of Biochemistry I, Medical Faculty, University of Cologne, Germany.

Human Mutation
|December 24, 2008
PubMed

Insights

This study identifies a truncated desmin protein as the cause of a rare myofibrillar myopathy. Protein levels vary significantly within muscle, complicating the determination of disease-causing thresholds.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Myofibrillar myopathies (MFMs) are a group of inherited muscle disorders.
  • Mutations in genes like desmin cause MFMs, often resulting in heterozygous single amino acid substitutions or small in-frame deletions.
  • Standard immunodetection techniques struggle to differentiate mutant from wild-type proteins in human skeletal muscle.

Purpose of the Study:

  • To investigate the molecular basis of an exceptional desminopathy.
  • To identify the specific disease-causing desmin mutation and its pathogenic mechanism.
  • To analyze the expression levels and distribution of mutant desmin in affected muscle tissue.

Main Methods:

  • Genetic analysis of patients with desminopathy.
  • Immunoblotting to detect desmin protein variants in skeletal muscle.
  • RT-PCR to identify desmin mRNA species.
  • Semiquantitative RT-PCR and protein quantification to assess mutant desmin levels.
  • In vitro desmin assembly studies.

Main Results:

  • A heterozygous c.735G>C mutation in desmin was identified in affected patients.
  • Skeletal muscle samples revealed full-length desmin and a truncated 50 kDa variant.
  • RT-PCR detected mRNA for wild-type desmin and two mutant forms: p.Glu245Asp and p.Asp214_Glu245del.
  • The truncated p.Asp214_Glu245del desmin was identified as the disease-causing mutant.
  • Truncated desmin mRNA ranged from 24% to 37%, but protein levels varied widely (5% to 43%) within and between muscle biopsies.

Conclusions:

  • The truncated p.Asp214_Glu245del desmin protein is pathogenic in myofibrillar myopathy.
  • High intra- and interindividual variability in mutant desmin protein levels complicates defining in vivo pathogenic thresholds.
  • The complex distribution of mutant protein reflects local expression and turnover differences within myonuclear domains.